Christine Lang

This inventor holds 20 USPTO granted patents and 26 published patent applications, plus 4 CIPO patents and 20 EPO patents, primarily in Microbial Biotechnology. Top assignees: Organobalance Gmbh, Novozymes A/s, Basf Se Corporation. Active years: 2004-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Lang. Retrieved from https://idiyas.com/inventor/christine-lang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 20 (Patent Applications = 26)

% Patents Active = 50.0

CIPO Patents = 4

EPO Patents = 20 (Patent Applications = 16)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 35(Granted Patents)

Company Filing History:

Organobalance Medical Ag

patents

5. 1 out of 10,816

Basf Aktiengesellschaft

patents

6. 1 out of 115

Technische Unversität Berlin

patents

7. 1 out of 834,601

Other

patents

Years Active: 2004-2022

Loading Chart...

Areas of Expertise:

Caries Prevention

Lactobacillus Strains

Skin Protection

Transgenic Organisms

Human Membrane Protein

Pentacyclic Triterpenes

Lactic Acid Bacteria

Peptides

Succinic Acid

Food Additives

Terpenes

Microbial Methods

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11419811 - Means and methods for preventing and/or treating caries (2022-08-23),

2. 11053474 - Lactobacillus strains and the uses thereof (2021-07-06),

3. 10953051 - Methods and means for protecting the skin against pathogenic microorganisms (2021-03-23),

4. 10385375 - Preparation of 7-dehydrocholesterol and/or the biosynthetic intermediates and/or secondary products thereof in transgenic organisms (2019-08-20),

5. 10308971 - Microorganism for expressing a human membrane protein (2019-06-04),

6. 10011838 - Yeast strain and microbial method for production of pentacyclic triterpenes and/or triterpenoids (2018-07-03),

7. 9920348 - Microorganism for expressing a human membrane protein (2018-03-20),

8. 9598710 - Genetically modified organism for the production of lipids (2017-03-21),

9. 9585922 - Lactic acid bacteria that co-aggregate with pathogenic bacteria (2017-03-07),

10. 9308227 - Lactic acid bacteria and compositions containing them against bacterial colds (2016-04-12),

11. 9220672 - Peptide for use in the treatment of skin conditions (2015-12-29),

12. 9051587 - Yeast cell for the production of terpenes and uses thereof (2015-06-09),

13. 8841114 - Genetically modified organism for the production of lipids (2014-09-23),

14. 8685704 - Microorganism for the production of succinic acid (2014-04-01),

15. 8506953 - Use and methods for preventing and/or treating oral malodour (2013-08-13),

Title: Innovator Spotlight: Christine Lang and Her Patents in Microbiology

Introduction

Christine Lang is a notable inventor based in Berlin, Germany, recognized for her significant contributions to the field of microbiology. With a remarkable portfolio of 20 patents, she has made strides in developing innovative solutions for preventing and treating dental caries, as well as enhancing food preservation, animal feed, and cosmetic compositions.

Latest Patents

One of her latest patents focuses on "Means and methods for preventing and/or treating caries." This patent describes a microorganism from the group of lactic acid bacteria that can specifically bind to certain surfaces under various conditions. The binding properties of this microorganism are resilient, maintaining functionality even under heat treatment or protease treatment. Additionally, it functions within a specific pH range and is effective in the presence of saliva. The invention also introduces analogs or fragments of this microorganism that retain the binding capabilities, thus expanding its application potential. Furthermore, it encompasses compositions and additives for foods, feeds, or drinks containing this microorganism, which can be used in anticariogenic pharmaceuticals or foodstuff.

Her other significant invention, "Lactobacillus strains and the uses thereof," highlights novel strains for food preservation, animal feed, and cosmetic products. These innovations underline her commitment to enhancing health and quality in various industries.

Career Highlights

Throughout her career, Christine has been associated with renowned companies such as Organobalance GmbH and Novozymes A/S. These experiences have allowed her to hone her expertise and drive innovation in the microbiological field.

Collaborations

Christine has collaborated with distinguished professionals such as Markus Veen and Andreas Raab. These partnerships have enriched her research and have contributed to the advancements reflected in her innovative patents.

Conclusion

Christine Lang exemplifies the essence of innovation in microbiology. Her patents not only tackle crucial health issues like dental caries but also enhance preservation across various sectors. As she continues to develop transformative inventions, her work stands as an inspiration for aspiring inventors and established innovators alike.

Profile summary based on public USPTO records.